NORTHERN TRUST CORP - VERRICA PHARMACEUTICALS INC ownership

VERRICA PHARMACEUTICALS INC's ticker is VRCA and the CUSIP is 92511W108. A total of 49 filers reported holding VERRICA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of VERRICA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$1,390,021
+18.2%
190,675
-4.0%
0.00%
Q1 2024$1,176,434
-19.2%
198,722
-0.1%
0.00%
Q4 2023$1,455,809
+99.9%
198,881
+6.1%
0.00%
Q3 2023$728,352
-33.3%
187,478
-0.9%
0.00%
Q2 2023$1,091,424
+226.6%
189,155
+267.9%
0.00%
Q1 2023$334,205
+154.2%
51,416
+7.5%
0.00%
Q4 2022$131,486
-6.7%
47,813
-0.7%
0.00%
Q3 2022$141,000
+76.2%
48,146
+16.2%
0.00%
Q2 2022$80,000
-92.7%
41,449
-69.5%
0.00%
Q1 2022$1,103,000
-13.9%
135,956
-2.8%
0.00%
Q4 2021$1,281,000
-27.1%
139,837
-0.4%
0.00%
Q3 2021$1,756,000
+5.8%
140,453
-4.4%
0.00%
Q2 2021$1,660,000
-27.9%
146,918
-3.3%
0.00%
Q1 2021$2,302,000
+12.5%
151,915
-14.6%
0.00%
Q4 2020$2,047,000
+41.0%
177,868
-5.2%
0.00%
Q3 2020$1,452,000
+11.3%
187,611
+58.4%
0.00%
Q2 2020$1,304,000
-21.3%
118,455
-21.9%
0.00%
Q1 2020$1,657,000
-26.1%
151,658
+7.5%
0.00%
-100.0%
Q4 2019$2,243,000
+11.5%
141,135
+3.5%
0.00%
Q3 2019$2,012,000
+55.6%
136,343
+22.5%
0.00%
Q2 2019$1,293,000
+11.6%
111,261
+3.8%
0.00%
Q1 2019$1,159,000
+112.3%
107,212
+60.0%
0.00%
Q4 2018$546,000
-46.1%
67,028
+7.5%
0.00%
Q3 2018$1,013,00062,3390.00%
Other shareholders
VERRICA PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Propel Bio Management, LLC 424,937$3,097,7912.01%
Perceptive Advisors 7,099,182$51,753,0371.25%
BML Capital Management, LLC 180,000$1,312,2000.94%
Avoro Capital Advisors LLC 3,999,999$29,159,9930.39%
Simplify Asset Management Inc. 280,000$2,041,2000.14%
EAM Investors, LLC 70,586$514,5720.08%
SteelPeak Wealth, LLC 122,836$895,4750.04%
SPC Financial, Inc. 30,000$218,7000.02%
Key FInancial Inc 9,415$68,6350.02%
Miracle Mile Advisors, LLC 84,000$612,3600.02%
View complete list of VERRICA PHARMACEUTICALS INC shareholders